FCGR2B and systemic lupus erythematosus: FcγRIIB influences humans’ susceptibility to several autoimmune diseases, including systemic lupus erythematosus, rheumatoid arthritis, anti-GBM disease, and idiopathic thrombocytopenic purpura [21].